SCHEMBL31106295

SCHEMBL31106295

CC(C)(C)OC(=O)N(C(=O)OC(C)(C)C)c1ccc(N2CCN(C(=O)OCc3ccccc3)CC2=O)cn1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TMEM97 Q5BJF2 9/20 0.39
SIGMAR1 Q99720 9/20 0.39
HTR1A P08908 1/20 0.39
ADRA2A P08913 1/20 0.39
ADRA2B P18089 1/20 0.39
ADRA2C P18825 1/20 0.39
DRD1 P21728 1/20 0.39
HRH2 P25021 1/20 0.39
HTR1B P28222 1/20 0.39
HTR2A P28223 1/20 0.39
HTR2C P28335 1/20 0.39
HTR1E P28566 1/20 0.39
SLC6A4 P31645 1/20 0.39
HRH1 P35367 1/20 0.39
HTR2B P41595 1/20 0.39
HRH3 Q9Y5N1 1/20 0.39
PARP1 P09874 1/20 0.39
F10 P00742 4/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19946670 1.00 TMEM97 (0.39) TMEM97SIGMAR1HTR1AADRA2AADRA2B
SCHEMBL31106303 0.81 PSEN1 (0.41) SLC6A4PARP1
SCHEMBL19960792 0.80 SMN1; SMN2 (0.45) TMEM97SIGMAR1HTR1AADRA2AADRA2B
SCHEMBL5592319 0.79 TMEM97 (0.43) TMEM97SIGMAR1HTR1AADRA2AADRA2B
SCHEMBL5592397 0.77 TMEM97 (0.47) TMEM97SIGMAR1HTR1AADRA2AADRA2B
SCHEMBL21800330 0.76 TMEM97 (0.60) TMEM97SIGMAR1HTR1AADRA2AADRA2B
SCHEMBL5836154 0.76 MEN1 (0.53) TMEM97SIGMAR1HTR1AADRA2AADRA2B
SCHEMBL1949475 0.76 HPGD (0.56) TMEM97SIGMAR1HTR1AADRA2AADRA2B
SCHEMBL28437194 0.75 HDAC1 (0.41) PARP1
SCHEMBL3322484 0.75 YAP1 (0.49) HRH1HRH3GPR119

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111333627-B Substituted 2-hydro-pyrazole derivatives as anticancer agents 正大天晴药业集团股份有限公司 2024-09-13 CN disclosed